Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0000950170-25-034006

Chief Financial Officer acquired 1,702 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelly John Alexander Chief Financial Officer 2025-03-03 Option exercise +1,702 86,256 D
Derivatives
Kelly John Alexander Chief Financial Officer 2025-03-03 Option exercise · Restricted Stock Units −1,702 0 D
Loading xslF345X05/ownership.xml…